Acute transverse myelitis after BNT162b2 vaccination against COVID-19: Report of a fatal case and review of the literature
J Neurol Sci
.
2022 Mar 15:434:120102.
doi: 10.1016/j.jns.2021.120102.
Epub 2021 Dec 20.
Authors
Hiroto Nakano
1
,
Kazuyoshi Yamaguchi
2
,
Kouhei Kawabata
2
,
Miwako Asakawa
2
,
Yasuko Matsumoto
2
Affiliations
1
Department of Neurology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan. Electronic address: neuro-nakano@med.kanazawa-u.ac.jp.
2
Department of Neurology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
PMID:
34953348
PMCID:
PMC8685167
DOI:
10.1016/j.jns.2021.120102
No abstract available
Keywords:
Acute transverse myelitis; BNT162b2; SARS-CoV-2; Steroid; Vaccination.
Publication types
Letter
Review
MeSH terms
BNT162 Vaccine
COVID-19* / prevention & control
Humans
Myelitis, Transverse* / etiology
SARS-CoV-2
Vaccination / adverse effects
Substances
BNT162 Vaccine